7 U.S. lawmakers have disclosed 24 IDEXX Laboratories, Inc. - trades under the STOCK Act — 13 buys and 11 sells between 2015 and 2026. Congress has been net buyers of IDXX, and their disclosed buys are up 28.4% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of IDXX, marked to the latest close — per-share (share counts aren't disclosed).
Lawmakers ranked by notional-weighted return on their disclosed IDXX buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-03-30 | Rohit Khanna | BUY | $1K–$15K | $557.09 | $566.93 2026-08-13 | +1.8% |
| 2026-01-13 | April McClain Delaney | SELL | $1K–$15K | $714.04 | $566.93 2026-08-13 | +20.6% exit |
| 2025-12-02 | April McClain Delaney | SELL | $1K–$15K | $732.73 | $566.93 2026-08-13 | +22.6% exit |
| 2025-10-29 | April McClain Delaney | SELL | $1K–$15K | $627.66 | $566.93 2026-08-13 | +58.1% rt |
| 2025-10-16 | April McClain Delaney | SELL | $1K–$15K | $637.34 | $566.93 2026-08-13 | +68.2% rt |
| 2025-09-04 | Byron Donalds | BUY | $1K–$15K | $640.44 | $566.93 2026-08-13 | -11.5% |
| 2025-08-07 | April McClain Delaney | SELL | $1K–$15K | $650.06 | $566.93 2026-08-13 | +65.1% rt |
| 2025-08-01 | April McClain Delaney | SELL | $1K–$15K | $535.54 | $566.93 2026-08-13 | +27.9% rt |
| 2025-07-09 | April McClain Delaney | SELL | $1K–$15K | $540.64 | $566.93 2026-08-13 | +30.2% rt |
| 2025-04-09 | April McClain Delaney | BUY | $1K–$15K | $397.10 | $566.93 2026-08-13 | +42.8% |
| 2025-04-07 | April McClain Delaney | BUY | $1K–$15K | $378.99 | $566.93 2026-08-13 | +49.6% |
| 2025-04-04 | April McClain Delaney | BUY | $1K–$15K | $393.73 | $566.93 2026-08-13 | +44.0% |
| 2025-04-01 | April McClain Delaney | BUY | $1K–$15K | $418.57 | $566.93 2026-08-13 | +35.4% |
| 2025-03-14 | April McClain Delaney | BUY | $1K–$15K | $415.30 | $566.93 2026-08-13 | +36.5% |
| 2024-01-22 | Thomas H Tuberville | SELL | $1K–$15K | $531.43 | $566.93 2026-08-13 | +8.6% rt |
| 2023-04-03 | Thomas H Tuberville | BUY | $1K–$15K | $489.27 | $566.93 2026-08-13 | +15.9% |
| 2023-04-03 | Thomas H Tuberville | BUY | $1K–$15K | $489.27 | $566.93 2026-08-13 | +15.9% |
| 2022-10-05 | Thomas H Tuberville | SELL | $1K–$15K | $350.12 | $566.93 2026-08-13 | -26.9% rt |
| 2021-03-29 | Thomas H Tuberville | BUY | $1K–$15K | $479.18 | $566.93 2026-08-13 | +18.3% |
| 2020-08-11 | Gilbert Cisneros | SELL | $1K–$15K | $374.03 | $566.93 2026-08-13 | -51.6% exit |
| 2017-04-05 | John K. Delaney | BUY | $1K–$15K | $154.72 | $566.93 2026-08-13 | +266.4% |
| 2017-03-09 | John K. Delaney | BUY | $1K–$15K | $149.41 | $566.93 2026-08-13 | +279.4% |
| 2017-03-07 | John K. Delaney | BUY | $1K–$15K | $147.03 | $566.93 2026-08-13 | +285.6% |
| 2015-06-02 | Lamar Smith | SELL | $1K–$15K | $67.03 | $566.93 2026-08-13 | -745.7% exit |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
7 members of the U.S. House and Senate have disclosed IDEXX Laboratories, Inc. - transactions under the STOCK Act — 13 purchases and 11 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a IDXX purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed IDXX buys are up 28.4% versus the latest close of $566.93. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded IDXX and how it performed.